Development of an eHealth Tool for Capturing and Analyzing the Immune-related Adverse Events (irAEs) in Cancer Treatment
Introduction: Immunotherapy has revolutionized the treatment of many different types of cancer, but it is associated with a myriad of immune-related adverse events (irAEs). Patient-reported outcome (PRO) measures have been identified as valuable tools for continuously collecting patient-centered dat...
Main Authors: | Saeed Moradian, Shive Ghasemi, Babak Boutorabi, Zakieh Sharifian, Fay Dastjerdi, Catriona Buick, Charlotte T. Lee, Samantha J Mayo, Plinio P. Morita, Doris Howell |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2023-06-01
|
Series: | Cancer Informatics |
Online Access: | https://doi.org/10.1177/11769351231178587 |
Similar Items
-
Hyperacute Radiation Pneumonitis after Severe irAE
by: Yang Chou, et al.
Published: (2024-04-01) -
Review of Immune-Related Adverse Events (irAEs) in Non-Small-Cell Lung Cancer (NSCLC)—Their Incidence, Management, Multiorgan irAEs, and Rechallenge
by: Raju Vaddepally, et al.
Published: (2022-03-01) -
Editorial: Immune-related adverse Events (irAEs) of biopharmaceuticals
by: Alexander Batista-Duharte, et al.
Published: (2023-05-01) -
4401 Incidence, management, and outcomes of immune-related adverse events (irAEs): an analysis of a multidisciplinary toxicity team for cancer immunotherapy related irAEs
by: Aanika Balaji, et al.
Published: (2020-06-01) -
A case of readministration of nivolumab by treating with apremilast for psoriasiform eruption as irAE
by: Naohisa Ichiki, et al.
Published: (2021-06-01)